Strides Shasun’s wholly owned subsidiary -- Strides Pharma Global has received final approval for Ibuprofen Tablets USP, 200 mg (OTC) from the United States Food & Drug Administration (USFDA). Ibuprofen Tablets 200 mg (OTC) is a generic version of Motrin IB Tablets, 200 mg, of Johnson & Johnson Consumer.
The product will be manufactured at the company’s Oral dosage facility at Puducherry and will be marketed by Strides Pharma in the US Market. The company has 75 cumulative ANDA filings with USFDA of which 51 ANDAs have been approved as of date and 24 are pending approval.
Strides Shasun is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The company manufactures range of soft gel in category of nutraceuticals, Rx, specialty OTCs and immunosuppressants.
